Back to top
more

Bionomics (BNOX)

(Delayed Data from NSDQ)

$0.28 USD

0.28
47,473

+0.01 (3.63%)

Updated Oct 11, 2024 03:58 PM ET

After-Market: $0.29 +0.01 (3.61%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (86 out of 250)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Company Summary

Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.

General Information

Bionomics Limited Unsponsored ADR

200 GREENHILL ROAD

EASTWOOD SA, C3 5063

Phone: 61-8-8150-7400

Fax: NA

Web: http://www.bionomics.com.au

Email: investorrelations@bionomics.com

Industry Medical - Biomedical and Genetics
Sector Medical
Fiscal Year End June
Last Reported Quarter 9/30/2024
Exp Earnings Date

This is an estimated date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.

NA

EPS Information

Current Quarter EPS Consensus Estimate NA
Current Year EPS Consensus Estimate -1.45
Estimated Long-Term EPS Growth Rate NA
Exp Earnings Date

This is an estimated date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.

NA

Price and Volume Information

Zacks Rank Premium
Yesterday's Close 0.27
52 Week High 4.73
52 Week Low 0.25
Beta NA
20 Day Moving Average 287,266.44
Target Price Consensus 6.00

BNOX

% Price Change
4 Week -57.51
12 Week -66.71
YTD -81.09
% Price Change Relative to S&P 500
4 Week -58.89
12 Week -68.49
YTD -84.49
Share Information
Shares Outstanding (millions) 8.16
Market Capitalization (millions) 2.28
Short Ratio NA
Last Split Date NA
Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio NA
Change in Payout Ratio NA
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E
P/E (F1) NA
Trailing 12 Months NA
PEG Ratio NA
EPS Growth
vs. Previous Year NA
vs. Previous Quarter NA
   
Sales Growth
vs. Previous Year NA%
vs. Previous Quarter NA%
   
Price Ratios
Price/Book 0.13
Price/Cash Flow NA
Price / Sales NA
ROE
9/30/24 NA
6/30/24 NA
3/31/24 NA
ROA
9/30/24 NA
6/30/24 NA
3/31/24 NA
Current Ratio
9/30/24 Pending Next EPS Report
6/30/24 3.45
3/31/24 NA
Quick Ratio
9/30/24 Pending Next EPS Report
6/30/24 3.45
3/31/24 NA
Operating Margin
9/30/24 NA
6/30/24 NA
3/31/24 NA
Net Margin
9/30/24 NA
6/30/24 NA
3/31/24 NA
Pre-Tax Margin
9/30/24 NA
6/30/24 NA
3/31/24 NA
Book Value
9/30/24 Pending Next EPS Report
6/30/24 2.14
3/31/24 NA
Inventory Turnover
9/30/24 NA
6/30/24 NA
3/31/24 NA
Debt-to-Equity
9/30/24 Pending Next EPS Report
6/30/24 0.00
3/31/24 NA
Debt to Capital
9/30/24 Pending Next EPS Report
6/30/24 0.00
3/31/24 NA